Evidence map›Paper›PMID 25403429›Full record

ReviewJournal of endocrinological investigation2015

Cross-sex hormone therapy for gender dysphoria.

B Fabris, S Bernardi, C Trombetta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of endocrinological investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Trans* Pregnancy and Lactation: A Literature Review from a Nursing Perspective.International journal of environmental research and public health · 2019
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Quality of life and hormones after sex reassignment surgery.Journal of endocrinological investigation · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

B FabrisDivision of Internal Medicine, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. b.fabris@fmc.units.it.
S BernardiDivision of Internal Medicine, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
C TrombettaDivision of Urology, Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
University of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGender identity is the sense one has of being male or female. Gender dysphoria (GD) refers to the distress caused by the incongruence between gender identity and biological sex in gender-nonconforming individuals. Cross-sex hormone therapy (CHT) aims at easing GD, improving well-being, and quality of life of gender-nonconforming individuals. This can be achieved by inducing and maintaining the desired-sex characteristics in accordance with the specific aspirations and expectations of each individual. Nevertheless, CHT can be associated with potentially serious long-term complications.

methodsHere, we review when, how, and how long to prescribe CHT to adult transsexuals as well as what to expect and monitor once it has been initiated.

resultsIn recent years, transsexualism has become more and more recognized and depathologized. To manage GD, National and International Standards of Care have been established. Nevertheless, the needs of transgender patients can still be ignored or dismissed. Moreover, some questions remain unanswered because of the lack of specific retrospective or prospective studies on CHT.

conclusionEducation and culturally sensitive training must be supplied to healthcare professionals to overcome the existing issues on GD management and change the perspectives of transsexual people.

Indexed as

Gender IdentityQuality of LifeAndrogen AntagonistsFemaleGender DysphoriaGonadal Steroid HormonesHumansMaleTranssexualismAndrogen AntagonistsGonadal Steroid HormonesAnti-androgensCross-sex hormone therapyEstrogensGender dysphoriaTestosteroneTranssexualism

Identifiers

PMID25403429
OpenAlexW1982707463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.